ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

Clinical Trials Approved By NCI Listed For September

September 24, 2004

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012